EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drugMarch 21, 2026Yahoo Finance
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drugMarch 21, 2026Yahoo Finance
Jefferies Upgrades Ultrapar Participações (UGP) to Market Perform, Raises PTMarch 21, 2026Yahoo Finance
LifeVantage Conference: Subscription Sales, LoveBiome Integration, and CEO Succession in FocusMarch 21, 2026Yahoo Finance
